Skip to content

The Effects of Diet and Exercise Interventions in Peripheral Artery Disease

The Effects of Diet and Exercise Interventions in Peripheral Artery Disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03845036
Enrollment
150
Registered
2019-02-19
Start date
2024-09-16
Completion date
2029-05-31
Last updated
2026-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Claudication, Peripheral Artery Disease

Brief summary

This study is a 3-month, prospective, randomized controlled clinical trial designed to address the efficacy of the DASH dietary program combined with a home-based exercise program, quantified by a step activity monitor, to improve exercise and vascular outcome measures in patients with PAD.

Detailed description

This study seeks to (1) compare the changes in 6-minute walk distance (6MWD) and physical function quality of life in patients with peripheral artery disease (PAD) following a combined intervention of the dietary approaches to stop hypertension (DASH) dietary program plus a home-based exercise program, and following a home-based exercise program alone; and (2) compare the changes in microvascular function and inflammation in patients following the combined DASH diet and home-based exercise program, and the home-based exercise program alone. The investigators hypothesize that the combined DASH diet and exercise program will result in greater increases in 6MWD and in the physical function quality of life than the exercise program alone. Further, it is hypothesized that the combined DASH diet and exercise program will result in greater improvements in calf muscle oxygen saturation \[StO2\] following exercise, and in high-sensitivity C-reactive protein (hsCRP\]) than the exercise program alone. The home-based exercise program consists of intermittent walking to moderate claudication pain in a home-based setting. The DASH dietary program consists of the dietary approaches to stop hypertension diet emphasizing foods rich in fruits, vegetables, whole grains, and low-fat dairy.

Interventions

BEHAVIORALDASH Diet plus Home-Based Exercise

The DASH dietary program consists of a diet emphasizing foods rich in fruits, vegetables, whole grains, and low-fat dairy, in which patients record daily servings of fruits and vegetables. The home-based exercise program consists of intermittent walking to moderate claudication pain 3 times per week for 3 months in a home-based setting.

BEHAVIORALHome-Based Exercise

The home-based exercise program consists of intermittent walking to moderate claudication pain 3 times per week for 3 months in a home-based setting.

Sponsors

University of Oklahoma
Lead SponsorOTHER
Milton S. Hershey Medical Center
CollaboratorOTHER
National Institute on Aging (NIA)
CollaboratorNIH
Case Western Reserve University
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Prospective, randomized controlled clinical trial

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. History of claudication, 2. Presence of PAD, defined by meeting at least one of the following criteria (ABI at rest \< 0.90, or \> 20% decrease in ABI following a heel-rise exercise test in patients with a normal ABI at rest (\> 0.90), or history of peripheral revascularization.

Exclusion criteria

1. absence of PAD, defined by meeting all of the following 3 criteria (ABI at rest \> 0.90), \< 20% decrease in ABI following a heel-rise exercise test, and no history of peripheral revascularization, 2. non-compressible vessels (ABI \> 1.40), 3. rest pain due to PAD (Fontaine stage III; Rutherford Grade II), 4. tissue loss due to PAD (Fontaine stage IV; Rutherford Grade III), 5. use of medications indicated for the treatment of intermittent claudication (cilostazol and pentoxifylline) initiated within three months prior to investigation, 6. peripheral revascularization within one month prior to investigation, 7. active cancer, 8. end stage renal disease defined as stage 5 chronic kidney disease, 9. medical conditions that are contraindicative for exercise according to the American College of Sports Medicine, 10. cognitive dysfunction (mini-mental state examination score \< 24), and 11. failure to complete the baseline tests within three weeks.

Design outcomes

Primary

MeasureTime frameDescription
Peak Walking Time3 monthsThe change in the time walked on a treadmill test
Physical Function subscale of quality of life from the Medical Outcomes Study Short-Form 36 questionnaire3 monthsThe change in the Physical Function subscale from the pre-test value to the post-test value

Secondary

MeasureTime frameDescription
calf muscle oxygen saturation3 monthsThe change in the calf muscle oxygen saturation value during exercise from the pre-test value to the post-test value
6-minute walk distance3 monthsThe change in 6-minute walk distance from the pre-test value to the post-test value
high-sensitivity C-reactive protein3 monthsThe change in the high-sensitivity C-reactive protein value from the pre-test value to the post-test value

Countries

United States

Contacts

CONTACTAndrew Gardner, Ph.D.
andrew-gardner@ouhsc.edu405-271-4742
PRINCIPAL_INVESTIGATORAndrew Gardner, Ph.D.

Professor, Department of Medicine, Cardiology

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 18, 2026